Cargando…

18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features

This study aimed to explore the correlation between imaging patterns and clinical features in patients with smoldering multiple myeloma (SMM) who simultaneously underwent 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor positron emission tomography/computed tomography (PET/CT). We retrieved and analyzed...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xiang, Dierks, Alexander, Kertels, Olivia, Kircher, Malte, Schirbel, Andreas, Samnick, Samuel, Buck, Andreas K., Knorz, Sebastian, Böckle, David, Scheller, Lukas, Messerschmidt, Janin, Barakat, Mohammad, Kortüm, K. Martin, Rasche, Leo, Einsele, Hermann, Lapa, Constantin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465161/
https://www.ncbi.nlm.nih.gov/pubmed/32824832
http://dx.doi.org/10.3390/cancers12082333
_version_ 1783577526931554304
author Zhou, Xiang
Dierks, Alexander
Kertels, Olivia
Kircher, Malte
Schirbel, Andreas
Samnick, Samuel
Buck, Andreas K.
Knorz, Sebastian
Böckle, David
Scheller, Lukas
Messerschmidt, Janin
Barakat, Mohammad
Kortüm, K. Martin
Rasche, Leo
Einsele, Hermann
Lapa, Constantin
author_facet Zhou, Xiang
Dierks, Alexander
Kertels, Olivia
Kircher, Malte
Schirbel, Andreas
Samnick, Samuel
Buck, Andreas K.
Knorz, Sebastian
Böckle, David
Scheller, Lukas
Messerschmidt, Janin
Barakat, Mohammad
Kortüm, K. Martin
Rasche, Leo
Einsele, Hermann
Lapa, Constantin
author_sort Zhou, Xiang
collection PubMed
description This study aimed to explore the correlation between imaging patterns and clinical features in patients with smoldering multiple myeloma (SMM) who simultaneously underwent 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor positron emission tomography/computed tomography (PET/CT). We retrieved and analyzed clinical characteristics and PET imaging data of 10 patients with SMM. We found a significant correlation between bone marrow (BM) plasma cell (PC) infiltration and mean standardized uptake values (SUV(mean)) of lumbar vertebrae L2-L4 on 11C-Methionine PET/CT scans (r = 0.676, p = 0.031) and 68Ga-Pentixafor PET/CT scans (r = 0.839, p = 0.002). However, there was no significant correlation between BM involvement and SUV(mean) of lumbar vertebrae L2-L4 on 18F-FDG PET/CT scans (r = 0.558, p = 0.093). Similarly, mean target-to-background ratios (TBR(mean)) of lumbar vertebrae L2-L4 also correlated with bone marrow plasma cell (BMPC) infiltration in 11C-Methionine PET/CT (r = 0.789, p = 0.007) and 68Ga-Pentixafor PET/CT (r = 0.724, p = 0.018) PET/CT. In contrast, we did not observe a significant correlation between BMPC infiltration rate and TBR(mean) in 18F-FDG PET/CT (r = 0.355, p = 0.313). Additionally, on 11C-Methionine PET/CT scans, we found a significant correlation between BMPC infiltration and TBR(max) of lumbar vertebrae L2-L4 (r = 0.642, p = 0.045). In conclusion, 11C-Methionine and 68Ga-Pentixafor PET/CT demonstrate higher sensitivity than 18F-FDG PET/CT in detecting BM involvement in SMM.
format Online
Article
Text
id pubmed-7465161
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74651612020-09-04 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features Zhou, Xiang Dierks, Alexander Kertels, Olivia Kircher, Malte Schirbel, Andreas Samnick, Samuel Buck, Andreas K. Knorz, Sebastian Böckle, David Scheller, Lukas Messerschmidt, Janin Barakat, Mohammad Kortüm, K. Martin Rasche, Leo Einsele, Hermann Lapa, Constantin Cancers (Basel) Article This study aimed to explore the correlation between imaging patterns and clinical features in patients with smoldering multiple myeloma (SMM) who simultaneously underwent 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor positron emission tomography/computed tomography (PET/CT). We retrieved and analyzed clinical characteristics and PET imaging data of 10 patients with SMM. We found a significant correlation between bone marrow (BM) plasma cell (PC) infiltration and mean standardized uptake values (SUV(mean)) of lumbar vertebrae L2-L4 on 11C-Methionine PET/CT scans (r = 0.676, p = 0.031) and 68Ga-Pentixafor PET/CT scans (r = 0.839, p = 0.002). However, there was no significant correlation between BM involvement and SUV(mean) of lumbar vertebrae L2-L4 on 18F-FDG PET/CT scans (r = 0.558, p = 0.093). Similarly, mean target-to-background ratios (TBR(mean)) of lumbar vertebrae L2-L4 also correlated with bone marrow plasma cell (BMPC) infiltration in 11C-Methionine PET/CT (r = 0.789, p = 0.007) and 68Ga-Pentixafor PET/CT (r = 0.724, p = 0.018) PET/CT. In contrast, we did not observe a significant correlation between BMPC infiltration rate and TBR(mean) in 18F-FDG PET/CT (r = 0.355, p = 0.313). Additionally, on 11C-Methionine PET/CT scans, we found a significant correlation between BMPC infiltration and TBR(max) of lumbar vertebrae L2-L4 (r = 0.642, p = 0.045). In conclusion, 11C-Methionine and 68Ga-Pentixafor PET/CT demonstrate higher sensitivity than 18F-FDG PET/CT in detecting BM involvement in SMM. MDPI 2020-08-18 /pmc/articles/PMC7465161/ /pubmed/32824832 http://dx.doi.org/10.3390/cancers12082333 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zhou, Xiang
Dierks, Alexander
Kertels, Olivia
Kircher, Malte
Schirbel, Andreas
Samnick, Samuel
Buck, Andreas K.
Knorz, Sebastian
Böckle, David
Scheller, Lukas
Messerschmidt, Janin
Barakat, Mohammad
Kortüm, K. Martin
Rasche, Leo
Einsele, Hermann
Lapa, Constantin
18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features
title 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features
title_full 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features
title_fullStr 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features
title_full_unstemmed 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features
title_short 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features
title_sort 18f-fdg, 11c-methionine, and 68ga-pentixafor pet/ct in patients with smoldering multiple myeloma: imaging pattern and clinical features
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465161/
https://www.ncbi.nlm.nih.gov/pubmed/32824832
http://dx.doi.org/10.3390/cancers12082333
work_keys_str_mv AT zhouxiang 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
AT dierksalexander 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
AT kertelsolivia 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
AT kirchermalte 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
AT schirbelandreas 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
AT samnicksamuel 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
AT buckandreask 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
AT knorzsebastian 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
AT bockledavid 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
AT schellerlukas 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
AT messerschmidtjanin 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
AT barakatmohammad 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
AT kortumkmartin 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
AT rascheleo 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
AT einselehermann 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
AT lapaconstantin 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures